Results 161 to 170 of about 1,041,860 (274)

What anabolic–androgenic steroids reveal about the limits of current harm reduction models

Addiction, EarlyView.
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski, Jason M. Nagata, Suzanne Nielsen   +2 more
wiley   +1 more source

Determining demographic risk factors for receiving counterfeit cancer drugs

Annals of Global Health, 2015
R. Cuomo, T. Ken Mackey
doaj   +1 more source

Testosterone abuse in Brazil: a growing public health challenge. [PDF]

Clinics (Sao Paulo)
Fregonesi A, Nascimento BCG, Junior JMS, Latronico AC, Abdo CHN, Sanvido LV, Junior AN, Junior FNF, Junior JB, Torres LO, Glina S, Hallak J, Ferreira E, Maciel G, Costa EMF, Hernandez AJ, Pedrinelli A, Ferriolli E, Baracat EC, Nahas WC, Gomes CM.   +20 more
europepmc   +1 more source

Contesting repression in divided democracies: Can counternarratives reduce support for police violence?

American Journal of Political Science, EarlyView.
Abstract Democracies often struggle to contain police violence, which undermines the rule of law and reproduces inequality by targeting marginalized citizens. Yet, scholars have shown that repressive policing enjoys considerable public support. Focusing on Brazil, we demonstrate that attitudes toward police violence mirror polarization between left ...
Yanilda María González, Natán Skigin
wiley   +1 more source

Changing Worlds, Changing Drug Markets. [PDF]

Nordisk Alkohol Nark
Hellman M.
europepmc   +1 more source

Potentiation effects of the positive allosteric modulator PTC‐174 on NMDA receptors in neonatal male rat substantia nigra dopaminergic neurons

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Positive allosteric modulators bind to secondary binding sites on the receptor and alter receptor conformation and activation, changing agonist potency and efficacy. PTC‐174 is a novel NMDA receptor positive allosteric modulator that particularly enhances activity of receptors containing GluN2C or GluN2D subunits.
Bangyuan Liu, Alasdair J. Gibb
wiley   +1 more source

Knowledge, practices, and recognition ability of counterfeit medicines among lebanese community pharmacists during concurrent national crises. [PDF]

Sci Rep
Mourad N, Haddad C, Sacre H, Tawil SA, Zeenny RM, Younes S, Rahal M, Mourad L, Baalbaki R, Hamdan M, Kanaan S, Salameh P.   +11 more
europepmc   +1 more source

NMDA receptor subunit‐dependent analysis of radiprodil inhibition in neonatal male rat substantia nigra dopaminergic neurons

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Radiprodil is a GluN2B subunit selective NMDA receptor negative allosteric modulator which is currently under clinical investigation as a possible anti‐epileptic drug for paediatric use. Our goal was to investigate the inhibition of dopaminergic neuron NMDA responses by radiprodil.
Bangyuan Liu, Alasdair J. Gibb
wiley   +1 more source

Current Approaches to Support Patients to Withdraw From Image and Performance Enhancing Drugs

Clinical Endocrinology, EarlyView.
ABSTRACT Image and performance‐enhancing drugs (IPEDs) include agents such as androgens, growth hormone, and erythropoietin, which are used to enhance appearance and physical performance. Androgens, also known as anabolic‐androgenic steroids (AAS), are the most used IPEDs worldwide.
Elizabeth Hyams, Bonnie Grant, Richard Quinton, Channa N. Jayasena   +3 more
wiley   +1 more source